Form 4: Cigna Group CEO David Cordani Executes Stock Option and Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Cigna Group's Chairman and CEO, David Cordani, exercised stock options and reported changes in his beneficial ownership of company stock, including transactions made under a pre-arranged Rule 10b5-1 trading plan.
Summary
- On March 26, 2024, David Cordani, Chairman & CEO of Cigna Group, executed a transaction involving common stock.
- Cordani exercised employee stock options to acquire 7,761 shares at a price of $139.22 per share.
- These transactions were executed under a pre-arranged Rule 10b5-1 trading plan adopted on May 15, 2023.
- Cordani also reported shares acquired through participation in The Cigna Group's 401(k) Plan, totaling 1,734.1237 shares.
- Following the reported transactions, Cordani directly owns 355,815 shares of Cigna Group common stock.
- Cordani also indirectly owns 99,918 shares through a GRAT and 153,801 shares through a trust.
Sentiment
Score: 6
Explanation: The sentiment is neutral. The filing reflects routine transactions by the CEO under a pre-existing trading plan. There's no indication of unusual activity or cause for concern.
Positives
- The CEO's participation in the company's 401(k) plan demonstrates confidence in the company's long-term prospects.
- The use of a pre-arranged Rule 10b5-1 trading plan suggests that the transactions were planned and not based on insider information.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. The exercise of stock options is a common occurrence for executives and can be seen as a positive sign of their confidence in the company's future.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the increase in outstanding shares from the option exercise.
- The filing provides transparency to stakeholders regarding the CEO's ownership stake in the company.
Key Dates
| Date | Description |
|---|---|
| 03/01/2016 | Date the employee stock option was granted. |
| 03/01/2017 | First vesting date of the employee stock option. |
| 05/15/2023 | Date the reporting person adopted the Rule 10b5-1 trading plan. |
| 03/26/2024 | Date of the reported transaction (stock option exercise). |
| 03/27/2024 | Date of the signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.